Systems, Methods, And Compositions For The Production of Water-Soluble Terpenes Derived From Cannabis Plants
The current inventive technology includes novel systems, methods and compositions for the in vivo production, modification and isolation of terpene compounds from Cannabis or other plants. In particular, the invention provides systems and methods for high level in vivo biosynthesis of water-soluble terpene compounds. In one preferred embodiment, the present invention generally relates to the conversion of Cannabis sativa or hemp derived terpenes into water-soluble terpene compounds, such as terpene glycosides, glycosylated-xylosylated terpenes, and an acetylated glycoside terpenes. In one preferred aspect, the invention may include system for producing water-soluble terpene compounds in yeast and tobacco cell suspension cultures, as well as an in planta system using transgenic Cannabis or hemp plants.
1 . An in vivo method for producing water-soluble terpenes comprising the steps:
genetically modified a yeast cell to express a nucleotide sequence encoding at least one heterologous glycosyltransferase, operably linked to a promotor, having glycosylation activity towards one or more terpenes;
establishing a suspension cell culture of genetically modified yeast cells;
introducing one or more terpenes to said suspension cell culture of genetically modified yeast cells; and
converting said one or more terpenes into one or more water-soluble glycosylated terpenes through the activity of said at least one heterologous glycosyltransferase.
2 . The method of claim 1 , wherein said genetically modified yeast cells comprise genetically modified yeast cells selected from the group consisting of: genetically modified Pichia pastoris cells, genetically modified Saccharomyces cerevisiae cells, and/or genetically modified Kluyveromyces marxianus cells.
3 . The method of claim 1 , wherein said nucleotide sequence encoding a heterologous glycosyltransferase having glycosylation activity towards one or more terpenes comprises a nucleotide sequence selected from the group consisting of: SEQ ID NO. 1; SEQ ID NO. 3; SEQ ID NO. 9; SEQ ID NO. 5; SEQ ID NO. 7; SEQ ID NO. 11; SEQ ID NO. 13; SEQ ID NO. 29; and SEQ ID NO. 31.
4 . The method of claim 1 , wherein said heterologous glycosyltransferase having glycosylation activity towards one or more terpenes comprises a heterologous glycosyltransferase selected from the group consisting of: UGT58A1; MhGt1; VvGt7; UGT94P1; Bs-YjiC; VvGT14; and a homolog protein having glycosylation activity towards one or more terpenes.
5 . The method of claim 1 , wherein said heterologous glycosyltransferase having glycosylation activity towards one or more terpenes comprises a heterologous glycosyltransferase selected from the group consisting of: SEQ ID NO. 2; SEQ ID NO. 4; SEQ ID NO. 10; SEQ ID NO. 6; SEQ ID NO. 8; (SEQ ID NO. 30; SEQ ID NO. 32; and a heterologous homolog protein having glycosylation activity towards one or more terpenes.
6 . The method of claim 1 , wherein said one or more water-soluble glycosylated terpenes comprises at least one water-soluble glycosylated terpene selected from the group consisting of: a terpene glycoside, a glycosylated-xylosylated terpene, and an acetylated glycoside terpene.
7 . The method of claim 1 , wherein said one or more water-soluble glycosylated terpenes comprises at least one water-soluble glycosylated terpene selected from the group consisting of: alpha-Bisabolyl monoglucoside, alpha-Bisabolyl O-acetyl glucoside, alpha-Bisabolyl oxidized glucoside, alpha-Bisabolyl diglucoside, Citronellyl monoglucoside, Geranyl O-acetyl glucoside, Geranyl monoglucoside, Linalyl monoglucoside, Linalyl glucoside-xyloside, Linalyl diglucoside, Neryl monoglucoside, Neryl diglucoside and Terpineol diglucoside.
8 . The method of claim 1 , wherein said step of introducing one or more terpenes to said suspension cell culture of genetically modified yeast cells comprises the step of introducing one or more isolated terpenes to the yeast suspension cell culture.
9 . The method of claim 1 , wherein said step of introducing one or more terpenes to said suspension cell culture of genetically modified yeast cells comprises the step of introducing a Cannabis extract having one or more terpenes to the yeast suspension cell culture.
10 . The method of claim 1 , wherein said step of introducing one or more terpenes to said suspension cell culture of genetically modified yeast cells comprises the step of introducing a full spectrum Cannabis extract having one or more terpenes and one or more cannabinoid to the yeast suspension cell culture.
11 . The method of claim 10 , wherein said heterologous glycosyltransferase having glycosylation activity towards one or more terpenes comprises a heterologous glycosyltransferase protein having glycosylation activity towards one or more terpenes and one or more cannabinoids.
12 . (canceled)
13 . The method of claim 11 , wherein said heterologous glycosyltransferase protein having glycosylation activity towards one or more terpenes and one or more cannabinoids comprises a glycosyltransferase protein selected from the group consisting of: SEQ ID NO. 12, and SEQ ID NO. 14, or an amino acid sequence having at least 90% sequence identity with SEQ ID NO. 12, and SEQ ID NO. 14, and that encodes a protein having glycosylation activity towards one or more terpenes and one or more cannabinoids.
14 - 84 . (canceled)
85 . A method for producing glycosylated terpenes comprising the steps:
introducing one or more terpene compounds to a glycosyltransferase enzyme, wherein the glycosyltransferase enzyme is selected from the group of amino acid sequences consisting of: SEQ ID NO. 2, 4, 6, 8, 10, 12, 14, 30, and 32.
glycosylating the one or more terpene compounds; and
isolating the glycosylated terpene compounds.
86 . The method of claim 85 , wherein said glycosylated terpene comprises at least one glycosylated terpene selected from the group consisting of: alpha-Bisabolyl monoglucoside, alpha-Bisabolyl O-acetyl glucoside, alpha-Bisabolyl oxidized glucoside, alpha-Bisabolyl diglucoside, Citronellyl monoglucoside, Geranyl O-acetyl glucoside, Geranyl monoglucoside, Linalyl monoglucoside, Linalyl glucoside-xyloside, Linalyl diglucoside, Neryl monoglucoside, Neryl diglucoside and Terpineol diglucoside.
87 . The method of claim 85 , wherein said step of introducing comprises the step of introducing the one or more terpene compounds with a glycosyltransferase enzyme in vitro, or with a glycosyltransferase enzyme expressed in vivo in a yeast cell, a bacterial cell, or a plant cell.
88 . A method comprising the steps:
providing a first quantity of a terpene compound and a first quantity of a cannabinoid compound;
introducing the terpene compound to a first glycosyltransferase, wherein the glycosyltransferase enzyme is selected from the group of amino acid sequences consisting of: SEQ ID NO. 2, 4, 6, 8, 10, 12, 14, 30, and 32; and
introducing the cannabinoid compound to a glycosyltransferase, wherein the glycosyltransferase enzyme is selected from the group of amino acid sequences consisting of: SEQ ID NO. 12, and SEQ ID NO. 14.
89 . The method of claim 88 , wherein said step of introducing comprises the step of introducing the one or more terpene compounds with a glycosyltransferase enzyme in vitro, or with a glycosyltransferase enzyme expressed in vivo in a yeast cell, a bacterial cell, or a plant cell.
90 . The method of claim 88 , wherein said glycosylated terpene comprises at least one glycosylated terpene selected from the group consisting of: alpha-Bisabolyl monoglucoside, alpha-Bisabolyl O-acetyl glucoside, alpha-Bisabolyl oxidized glucoside, alpha-Bisabolyl diglucoside, Citronellyl monoglucoside, Geranyl O-acetyl glucoside, Geranyl monoglucoside, Linalyl monoglucoside, Linalyl glucoside-xyloside, Linalyl diglucoside, Neryl monoglucoside, Neryl diglucoside and Terpineol diglucoside.
91 . The method of claim 88 , wherein said cannabinoid compound is selected from the group consisting of: cannabidiol (CBD), and tetrahydrocannabinol (THC).
92 . The method of claim 11 , wherein said cannabinoid compound is selected from the group consisting of: cannabidiol (CBD), and tetrahydrocannabinol (THC).